The JAK2 pathway plays a critical role in PRL-induced proliferation of normal mammary epithelial cells, as well as in human breast cancer cells [49–51], and we have previously shown that PRL induces proliferation of different breast cancer cells [52]. Here, JAK2 is linked to breast carcinoma.